174 related articles for article (PubMed ID: 20373865)
1. Are tumoral factors responsible for host tissue wasting in cancer cachexia?
Tisdale MJ
Future Oncol; 2010 Apr; 6(4):503-13. PubMed ID: 20373865
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of cancer cachexia.
Tisdale MJ
Physiol Rev; 2009 Apr; 89(2):381-410. PubMed ID: 19342610
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of cancer cachexia.
Tisdale MJ
J Support Oncol; 2003; 1(3):159-68. PubMed ID: 15334872
[TBL] [Abstract][Full Text] [Related]
4. Tumor-host interactions.
Tisdale MJ
J Cell Biochem; 2004 Nov; 93(5):871-7. PubMed ID: 15449322
[TBL] [Abstract][Full Text] [Related]
5. Cancer cachexia.
Tisdale MJ
Langenbecks Arch Surg; 2004 Aug; 389(4):299-305. PubMed ID: 15168125
[TBL] [Abstract][Full Text] [Related]
6. Waste management - cytokines, growth factors and cachexia.
Saini A; Al-Shanti N; Stewart CE
Cytokine Growth Factor Rev; 2006 Dec; 17(6):475-86. PubMed ID: 17118696
[TBL] [Abstract][Full Text] [Related]
7. Cancer cachexia.
Tisdale MJ
Curr Opin Gastroenterol; 2010 Mar; 26(2):146-51. PubMed ID: 19918173
[TBL] [Abstract][Full Text] [Related]
8. Cytokines and cancer anorexia cachexia syndrome.
Bennani-Baiti N; Davis MP
Am J Hosp Palliat Care; 2008; 25(5):407-11. PubMed ID: 18403577
[TBL] [Abstract][Full Text] [Related]
9. TNF-α and cancer cachexia: Molecular insights and clinical implications.
Patel HJ; Patel BM
Life Sci; 2017 Feb; 170():56-63. PubMed ID: 27919820
[TBL] [Abstract][Full Text] [Related]
10. The 'cancer cachectic factor'.
Tisdale MJ
Support Care Cancer; 2003 Feb; 11(2):73-8. PubMed ID: 12560934
[TBL] [Abstract][Full Text] [Related]
11. [Molecular and cellular biological analysis on cancer cachexia syndrome].
Mukaiyama T
Gan To Kagaku Ryoho; 2001 Jul; 28(7):883-91. PubMed ID: 11478136
[TBL] [Abstract][Full Text] [Related]
12. Catabolic mediators of cancer cachexia.
Tisdale MJ
Curr Opin Support Palliat Care; 2008 Dec; 2(4):256-61. PubMed ID: 19069310
[TBL] [Abstract][Full Text] [Related]
13. Anti-TNF treatment reduces rat skeletal muscle wasting in monocrotaline-induced cardiac cachexia.
Steffen BT; Lees SJ; Booth FW
J Appl Physiol (1985); 2008 Dec; 105(6):1950-8. PubMed ID: 18801959
[TBL] [Abstract][Full Text] [Related]
14. Zinc-alpha2-glycoprotein in cachexia and obesity.
Tisdale MJ
Curr Opin Support Palliat Care; 2009 Dec; 3(4):288-93. PubMed ID: 19823091
[TBL] [Abstract][Full Text] [Related]
15. Evidence for a novel serum factor distinct from zinc alpha-2 glycoprotein that promotes body fat loss early in the development of cachexia.
Byerley LO; Lee SH; Redmann S; Culberson C; Clemens M; Lively MO
Nutr Cancer; 2010; 62(4):484-94. PubMed ID: 20432169
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of skeletal muscle atrophy in cancer cachexia by D-myo-inositol 1,2,6-triphosphate.
Russell ST; Siren PM; Siren MJ; Tisdale MJ
Cancer Chemother Pharmacol; 2009 Aug; 64(3):517-27. PubMed ID: 19112551
[TBL] [Abstract][Full Text] [Related]
17. The biological mechanisms of cancer-related skeletal muscle wasting: the role of progressive resistance exercise.
Al-Majid S; Waters H
Biol Res Nurs; 2008 Jul; 10(1):7-20. PubMed ID: 18705151
[TBL] [Abstract][Full Text] [Related]
18. Cancer cachexia results in an increase in TNF-alpha receptor gene expression in both skeletal muscle and adipose tissue.
Figueras M; Busquets S; Carbó N; Almendro V; Argilés JM; López-Soriano FJ
Int J Oncol; 2005 Sep; 27(3):855-60. PubMed ID: 16077938
[TBL] [Abstract][Full Text] [Related]
19. New cachexic factors.
Tisdale MJ
Curr Opin Clin Nutr Metab Care; 1998 May; 1(3):253-6. PubMed ID: 10565357
[TBL] [Abstract][Full Text] [Related]
20. Cytokines in the pathogenesis of cancer cachexia.
Argilés JM; Busquets S; López-Soriano FJ
Curr Opin Clin Nutr Metab Care; 2003 Jul; 6(4):401-6. PubMed ID: 12806213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
